{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:34:09Z","timestamp":1794645249218,"version":"4.9.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32130058, 32561160090"],"award-info":[{"award-number":["32130058, 32561160090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24J22800600"],"award-info":[{"award-number":["24J22800600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The tumour microenvironment (TME) causes mitochondrial dysfunction in resident dendritic cells (DCs), resulting in inadequate antigen presentation and weak T cell priming. Herein, we identify hypoxia as a key factor for causing pathological mitochondrial fission in tumour-associated DCs, and develop a plant vesicle-DC chimera to relieve hypoxia-induced mitochondrial dysfunction for enhancing cancer immunotherapy. The biohybrid chimera is fabricated by loading algae-derived nanovesicles (ANVs) with genetically engineered CCR2 overexpressing-DCs. The CCR2-DC-ANVs target tumour by leveraging the C-C motif chemokine ligand 2 (CCL2) in tumours. Upon light exposure, the ANVs produce oxygen and NADPH to resolve hypoxic and oxidative stress, which reverse pathological mitochondrial fission in DCs. Mitochondrial network restoration alleviates endoplasmic reticulum stress, reduces lipid droplet accumulation, and initiates metabolic reprogramming to enhance antigen presentation and T cell priming of CCR2-DC-ANVs in the TME. The biohybrid chimera enhances therapeutic efficiency in humanized mouse models of breast cancer in female mice without requiring external tumour antigens. This approach highlights a cross-species chimera for next-generation DC therapy, and provides the basis for a nanobiotechnology platform to facilitate organelle medicine by combining photosynthesis with immunotherapy.<\/jats:p>","DOI":"10.1038\/s41467-026-73788-5","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:25:31Z","timestamp":1779981931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A plant vesicle-dendritic cell chimera for enhancing cancer immunotherapy"],"prefix":"10.1038","volume":"17","author":[{"given":"Wenzhe","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5969-6407","authenticated-orcid":false,"given":"Qi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3005-4272","authenticated-orcid":false,"given":"Dangge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-6966","authenticated-orcid":false,"given":"Yaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"73788_CR1","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman, I., Chen, D. S., Powles, T. & Turley, S. J. The cancer-immunity cycle: indication, genotype, and immunotype. Immunity 56, 2188\u20132205 (2023).","journal-title":"Immunity"},{"key":"73788_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.trecan.2022.10.006","volume":"9","author":"M Zagorulya","year":"2023","unstructured":"Zagorulya, M. & Spranger, S. Once upon a prime: DCs shape cancer immunity. Trends Cancer 9, 172\u2013184 (2023).","journal-title":"Trends Cancer"},{"key":"73788_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.omto.2019.03.007","volume":"13","author":"RA Belderbos","year":"2019","unstructured":"Belderbos, R. A., Aerts, J. & Vroman, H. Enhancing dendritic cell therapy in solid tumours with immunomodulating conventional treatment. Mol. Ther. Oncolytics 13, 67\u201381 (2019).","journal-title":"Mol. Ther. Oncolytics"},{"key":"73788_CR4","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.ccell.2024.05.025","volume":"42","author":"G Espinosa-Carrasco","year":"2024","unstructured":"Espinosa-Carrasco, G. et al. Intratumoural immune triads are required for immunotherapy-mediated elimination of solid tumours. Cancer Cell 42, 1202\u20131216 (2024).","journal-title":"Cancer Cell"},{"key":"73788_CR5","doi-asserted-by":"publisher","first-page":"e16523","DOI":"10.15252\/emmm.202216523","volume":"14","author":"A Martinez-Usatorre","year":"2022","unstructured":"Martinez-Usatorre, A. & De Palma, M. Dendritic cell cross-dressing and tumour immunity. EMBO Mol. Med. 14, e16523 (2022).","journal-title":"EMBO Mol. Med."},{"key":"73788_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala, S., Hammer, C. & Delamarre, L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat. Rev. Cancer 21, 298\u2013312 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"73788_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger, S., Bao, R. & Gajewski, T. F. Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature 523, 231\u2013235 (2015).","journal-title":"Nature"},{"key":"73788_CR8","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, J. P. et al. NK Cells stimulate recruitment of cDC1 into the tumour microenvironment promoting cancer immune control. Cell 172, 1022\u20131037 (2018).","journal-title":"Cell"},{"key":"73788_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccell.2020.02.008","volume":"37","author":"S Hegde","year":"2020","unstructured":"Hegde, S. et al. Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer. Cancer Cell 37, 289\u2013307 (2020).","journal-title":"Cancer Cell"},{"key":"73788_CR10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s42255-023-00783-1","volume":"5","author":"AS Monzel","year":"2023","unstructured":"Monzel, A. S., Enriquez, J. A. & Picard, M. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat. Metab. 5, 546\u2013562 (2023).","journal-title":"Nat. Metab."},{"key":"73788_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-018-0177-0","volume":"558","author":"XR Du","year":"2018","unstructured":"Du, X. R. et al. Hippo\/Mst signalling couples metabolic state and immune function of CD8\u03b1+ dendritic cells. Nature 558, 141\u2013145 (2018).","journal-title":"Nature"},{"key":"73788_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/cm.20175","volume":"64","author":"Z Zeng","year":"2007","unstructured":"Zeng, Z. et al. Tumour-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton. Cell Motil. Cytoskelet. 64, 186\u2013198 (2007).","journal-title":"Cell Motil. Cytoskelet."},{"key":"73788_CR13","doi-asserted-by":"publisher","first-page":"71.02","DOI":"10.4049\/jimmunol.210.Supp.71.02","volume":"210","author":"BL Vagher","year":"2023","unstructured":"Vagher, B. L. & Amiel, E. UDP-glucose regulates dendritic cell mitochondrial respiration via a nitric oxide-dependent mechanism. J. Immunol. 210, 71.02 (2023).","journal-title":"J. Immunol."},{"key":"73788_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02186-9","volume":"8","author":"F Veglia","year":"2017","unstructured":"Veglia, F. et al. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer. Nat. Commun. 8, 2122 (2017).","journal-title":"Nat. Commun."},{"key":"73788_CR15","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","volume":"161","author":"R Cubillos-Ruiz, Juan","year":"2015","unstructured":"Cubillos-Ruiz, Juan, R. et al. ER stress sensor XBP1 controls anti-tumour immunity by disrupting dendritic cell homeostasis. Cell 161, 1527\u20131538 (2015).","journal-title":"Cell"},{"key":"73788_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1470-2045(13)70585-0","volume":"15","author":"S Anguille","year":"2014","unstructured":"Anguille, S., Smits, E. L., Lion, E., van Tendeloo, V. F. & Berneman, Z. N. Clinical use of dendritic cells for cancer therapy. Lancet Oncol. 15, 257\u2013267 (2014).","journal-title":"Lancet Oncol."},{"key":"73788_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao5931","volume":"10","author":"JL Tanyi","year":"2018","unstructured":"Tanyi, J. L. et al. Personalized cancer vaccine effectively mobilizes antitumour T cell immunity in ovarian cancer. Sci. Transl. Med. 10, eaao5931 (2018).","journal-title":"Sci. Transl. Med."},{"key":"73788_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejca.2022.03.015","volume":"169","author":"SP Lau","year":"2022","unstructured":"Lau, S. P. et al. Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: a phase I study. Eur. J. Cancer 169, 20\u201331 (2022).","journal-title":"Eur. J. Cancer"},{"key":"73788_CR19","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/s41565-024-01758-3","volume":"19","author":"MX Tan","year":"2024","unstructured":"Tan, M. X. et al. Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade. Nat. Nanotechnol. 19, 1903\u20131913 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"73788_CR20","doi-asserted-by":"publisher","first-page":"2211415","DOI":"10.1002\/adma.202211415","volume":"35","author":"CC Xu","year":"2023","unstructured":"Xu, C. C. et al. Slimming and reinvigorating tumour-associated dendritic cells with hierarchical lipid rewiring nanoparticles. Adv. Mater. 35, 2211415 (2023).","journal-title":"Adv. Mater."},{"key":"73788_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101618","volume":"46","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Reprogramming dysfunctional dendritic cells by a versatile metabolism nano-intervenor for enhancing cancer combinatorial immunotherapy. Nano Today 46, 101618 (2022).","journal-title":"Nano Today"},{"key":"73788_CR22","doi-asserted-by":"publisher","first-page":"101648","DOI":"10.1016\/j.xcrm.2024.101648","volume":"5","author":"LH Shang","year":"2024","unstructured":"Shang, L. H. et al. Mitochondrial DNA-boosted dendritic cell-based nanovaccination triggers antitumour immunity in lung and pancreatic cancers. Cell Rep. Med. 5, 101648 (2024).","journal-title":"Cell Rep. Med."},{"key":"73788_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","volume":"618","author":"LA Rojas","year":"2023","unstructured":"Rojas, L. A. et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature 618, 144\u2013150 (2023).","journal-title":"Nature"},{"key":"73788_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41587-023-01796-7","volume":"42","author":"D Ji","year":"2024","unstructured":"Ji, D., Zhang, Y., Sun, J. et al. An engineered influenza virus to deliver antigens for lung cancer vaccination. Nat. Biotechnol. 42, 518\u2013528 (2024).","journal-title":"Nat. Biotechnol."},{"key":"73788_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41587-019-0390-x","volume":"38","author":"GM Lynn","year":"2020","unstructured":"Lynn, G. M., Sedlik, C., Baharom, F. et al. Peptide\u2013TLR-7\/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumour antigens. Nat. Biotechnol. 38, 320\u2013332 (2020).","journal-title":"Nat. Biotechnol."},{"key":"73788_CR26","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","volume":"37","author":"L Miao","year":"2019","unstructured":"Miao, L., Li, L., Huang, Y. et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumour efficacy by STING-mediated immune cell activation. Nat. Biotechnol. 37, 1174\u20131185 (2019).","journal-title":"Nat. Biotechnol."},{"key":"73788_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L., Buqu\u00e9, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97\u2013111 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"73788_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","volume":"44","author":"H Salmon","year":"2016","unstructured":"Salmon, H. et al. Expansion and activation of CD103+ dendritic cell progenitors at the tumour site enhances tumour responses to therapeutic PD-L1 and BRAF inhibition. Immunity 44, 924\u2013938 (2016).","journal-title":"Immunity"},{"key":"73788_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek, S. K. et al. Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7\u201324 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"73788_CR30","doi-asserted-by":"publisher","first-page":"eabm9409","DOI":"10.1126\/sciimmunol.abm9409","volume":"7","author":"E Kvedaraite","year":"2022","unstructured":"Kvedaraite, E. & Ginhoux, F. Human dendritic cells in cancer. Sci. Immunol. 7, eabm9409 (2022).","journal-title":"Sci. Immunol."},{"key":"73788_CR31","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.2217\/nnm-2017-0254","volume":"12","author":"CB Chesson","year":"2017","unstructured":"Chesson, C. B. & Zloza, A. Nanoparticles: augmenting tumour antigen presentation for vaccine and immunotherapy treatments of cancer. Nanomedicine 12, 2693\u20132706 (2017).","journal-title":"Nanomedicine"},{"key":"73788_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41573-020-0074-8","volume":"19","author":"A Harari","year":"2020","unstructured":"Harari, A., Graciotti, M., Bassani-Sternberg, M. & Kandalaft, L. E. Antitumour dendritic cell vaccination in a priming and boosting approach. Nat. Rev. Drug Discov. 19, 635\u2013652 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"73788_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.trecan.2017.12.007","volume":"4","author":"M Saxena","year":"2018","unstructured":"Saxena, M. & Bhardwaj, N. Re-emergence of dendritic cell vaccines for cancer treatment. Trends Cancer 4, 119\u2013137 (2018).","journal-title":"Trends Cancer"},{"key":"73788_CR34","doi-asserted-by":"publisher","first-page":"620374","DOI":"10.3389\/fimmu.2020.620374","volume":"11","author":"D Stevens","year":"2021","unstructured":"Stevens, D., Ingels, J., Van Lint, S., Vandekerckhove, B. & Vermaelen, K. Dendritic cell-based immunotherapy in lung cancer. Front. Immunol. 11, 620374 (2021).","journal-title":"Front. Immunol."},{"key":"73788_CR35","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1038\/s42255-024-01149-x","volume":"6","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Farnesyl pyrophosphate potentiates dendritic cell migration in autoimmunity through mitochondrial remodelling. Nat. Metab. 6, 2118\u20132137 (2024).","journal-title":"Nat. Metab."},{"key":"73788_CR36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41586-024-07340-0","volume":"629","author":"RZ Lin","year":"2024","unstructured":"Lin, R. Z., Im, G. B., Luo, A. C. et al. Mitochondrial transfer mediates endothelial cell engraftment through mitophagy. Nature 629, 660\u2013668 (2024).","journal-title":"Nature"},{"key":"73788_CR37","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1016\/j.cell.2024.08.029","volume":"187","author":"JG Baldwin","year":"2024","unstructured":"Baldwin, J. G. et al. Intercellular nanotube-mediated mitochondrial transfer enhances cell metabolic fitness and antitumour efficacy. Cell 187, 6614\u20136630 (2024).","journal-title":"Cell"},{"key":"73788_CR38","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.immuni.2013.08.004","volume":"39","author":"N Gehrke","year":"2013","unstructured":"Gehrke, N. et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 39, 482\u2013495 (2013).","journal-title":"Immunity"},{"key":"73788_CR39","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41586-022-05499-y","volume":"612","author":"PF Chen","year":"2022","unstructured":"Chen, P. F. et al. A plant-derived natural photosynthetic system for improving cell anabolism. Nature 612, 546\u2013554 (2022).","journal-title":"Nature"},{"key":"73788_CR40","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1093\/plphys\/kiac541","volume":"191","author":"AU Igamberdiev","year":"2023","unstructured":"Igamberdiev, A. U. & Bykova, N. Mitochondria in photosynthetic cells: coordinating redox control and energy balance. Plant Physiol. 191, 2104\u20132119 (2023).","journal-title":"Plant Physiol."},{"key":"73788_CR41","doi-asserted-by":"crossref","unstructured":"Tang, H. et al. Rescuing dendritic cell interstitial motility sustains antitumour immunity. Nature 645, 244\u2013253 (2025).","DOI":"10.1038\/s41586-025-09202-9"},{"key":"73788_CR42","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S1074-7613(00)80615-9","volume":"9","author":"B de Saint-Vis","year":"1998","unstructured":"de Saint-Vis, B. et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9, 325\u2013336 (1998).","journal-title":"Immunity"},{"key":"73788_CR43","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3389\/fimmu.2019.01312","volume":"10","author":"ZD Li","year":"2019","unstructured":"Li, Z. D. et al. CD83: activation marker for antigen presenting cells and its therapeutic potential. Front. Immunol. 10, 1312 (2019).","journal-title":"Front. Immunol."},{"key":"73788_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1084\/jem.20092203","volume":"208","author":"LE Tze","year":"2011","unstructured":"Tze, L. E. et al. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J. Exp. Med. 208, 149\u2013165 (2011).","journal-title":"J. Exp. Med."},{"key":"73788_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56666-4","volume":"16","author":"I Shiiba","year":"2025","unstructured":"Shiiba, I. et al. ER-mitochondria contacts mediate lipid radical transfer via RMDN3\/PTPIP51 phosphorylation to reduce mitochondrial oxidative stress. Nat. Commun. 16, 1508 (2025).","journal-title":"Nat. Commun."},{"key":"73788_CR46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41586-023-06857-0","volume":"625","author":"C Moschandrea","year":"2024","unstructured":"Moschandrea, C. et al. Mitochondrial dysfunction abrogates dietary lipid processing in enterocytes. Nature 625, 385\u2013392 (2024).","journal-title":"Nature"},{"key":"73788_CR47","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41586-021-03510-6","volume":"593","author":"T Kleele","year":"2021","unstructured":"Kleele, T. et al. Distinct fission signatures predict mitochondrial degradation or biogenesis. Nature 593, 435\u2013439 (2021).","journal-title":"Nature"},{"key":"73788_CR48","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s43018-023-00563-6","volume":"4","author":"PK Parida","year":"2023","unstructured":"Parida, P. K. et al. Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases. Nat. Cancer 4, 893\u2013907 (2023).","journal-title":"Nat. Cancer"},{"key":"73788_CR49","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1074\/jbc.M607279200","volume":"282","author":"N Taguchi","year":"2007","unstructured":"Taguchi, N. et al. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J. Biol. Chem. 282, 11521\u201311529 (2007).","journal-title":"J. Biol. Chem."},{"key":"73788_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel, T. R., Lill, J. K. & Altenburger, L. M. How chemokines organize the tumour microenvironment. Nat. Rev. Cancer 24, 28\u201350 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"73788_CR51","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222\u2013225 (2011).","journal-title":"Nature"},{"key":"73788_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202406140","volume":"36","author":"L Wu","year":"2024","unstructured":"Wu, L. et al. Dual-engineered macrophage-microbe encapsulation for metastasis immunotherapy. Adv. Mater. 36, e2406140 (2024).","journal-title":"Adv. Mater."},{"key":"73788_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29647-0","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H. et al. Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration. Nat. Commun. 13, 2154 (2022).","journal-title":"Nat. Commun."},{"key":"73788_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr4058","volume":"17","author":"M Sun","year":"2025","unstructured":"Sun, M. et al. Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models. Sci. Transl. Med. 17, eadr4058 (2025).","journal-title":"Sci. Transl. Med."},{"key":"73788_CR55","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41568-023-00574-6","volume":"23","author":"B Banushi","year":"2023","unstructured":"Banushi, B., Joseph, S. R., Lum, B., Lee, J. J. & Simpson, F. Endocytosis in cancer and cancer therapy. Nat. Rev. Cancer 23, 450\u2013473 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"73788_CR56","doi-asserted-by":"publisher","first-page":"11030424","DOI":"10.3390\/biom11030424","volume":"11","author":"HJ Ko","year":"2021","unstructured":"Ko, H. J. et al. The phosphorylation status of Drp1-Ser637 by PKA in mitochondrial fission modulates mitophagy via PINK1\/Parkin to exert multipolar spindles assembly during mitosis. Biomolecules 11, 11030424 (2021).","journal-title":"Biomolecules"},{"key":"73788_CR57","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41589-022-01224-y","volume":"19","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction. Nat. Chem. Bio. 19, 468\u2013477 (2023).","journal-title":"Nat. Chem. Bio."},{"key":"73788_CR58","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2017.08.013","volume":"67","author":"M Morita","year":"2017","unstructured":"Morita, M. et al. mTOR Controls Mitochondrial Dynamics And Cell Survival via MTFP1. Mol. Cell 67, 922\u2013935 (2017).","journal-title":"Mol. Cell"},{"key":"73788_CR59","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","volume":"20","author":"X Zheng","year":"2019","unstructured":"Zheng, X. et al. Mitochondrial fragmentation limits NK cell-based tumour immunosurveillance. Nat. Immunol. 20, 1656\u20131667 (2019).","journal-title":"Nat. Immunol."},{"key":"73788_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1653","volume":"14","author":"Y Xiao","year":"2024","unstructured":"Xiao, Y. et al. Mitochondrial dysfunction induced by HIF-1\u03b1 under hypoxia contributes to the development of gastric mucosal lesions. Clin. Transl. Med. 14, e1653 (2024).","journal-title":"Clin. Transl. Med."},{"key":"73788_CR61","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41586-023-06038-z","volume":"617","author":"A Bhowmick","year":"2023","unstructured":"Bhowmick, A. et al. Structural evidence for intermediates during O(2) formation in photosystem II. Nature 617, 629\u2013636 (2023).","journal-title":"Nature"},{"key":"73788_CR62","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-023-06008-5","volume":"617","author":"P Greife","year":"2023","unstructured":"Greife, P. et al. The electron-proton bottleneck of photosynthetic oxygen evolution. Nature 617, 623\u2013628 (2023).","journal-title":"Nature"},{"key":"73788_CR63","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/cdd.2012.74","volume":"19","author":"T Verfaillie","year":"2012","unstructured":"Verfaillie, T. et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ. 19, 1880\u20131891 (2012).","journal-title":"Cell Death Differ."},{"key":"73788_CR64","first-page":"97","volume":"12","author":"HR Wang","year":"2022","unstructured":"Wang, H. R. et al. Photosynthetic microorganisms coupled photodynamic therapy for enhanced antitumour immune effect. Bioact. Mater. 12, 97\u2013106 (2022).","journal-title":"Bioact. Mater."},{"key":"73788_CR65","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","volume":"25","author":"C Luri-Rey","year":"2025","unstructured":"Luri-Rey, C. et al. Cross-priming in cancer immunology and immunotherapy. Nat. Rev. Cancer 25, 249\u2013273 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"73788_CR66","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2023.12.011","volume":"187","author":"Y Shapir Itai","year":"2024","unstructured":"Shapir Itai, Y. et al. Bispecific dendritic-T cell engager potentiates anti-tumour immunity. Cell 187, 375\u2013389 (2024).","journal-title":"Cell"},{"key":"73788_CR67","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ccell.2023.12.010","volume":"42","author":"ME Hoekstra","year":"2024","unstructured":"Hoekstra, M. E. et al. Distinct spatiotemporal dynamics of CD8(+) T cell-derived cytokines in the tumour microenvironment. Cancer Cell 42, 157\u2013167 (2024).","journal-title":"Cancer Cell"},{"key":"73788_CR68","doi-asserted-by":"publisher","first-page":"14765","DOI":"10.1073\/pnas.93.25.14765","volume":"93","author":"F Yuan","year":"1996","unstructured":"Yuan, F. et al. Time-dependent vascular regression and permeability changes in established human tumour xenografts induced by an anti-vascular endothelial growth factor vascular permeability factor antibody. Proc. Natl. Acad. Sci. Usa. 93, 14765\u201314770 (1996).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"73788_CR69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature22311","volume":"545","author":"T Kammertoens","year":"2017","unstructured":"Kammertoens, T. et al. Tumour ischaemia by interferon-\u03b3 resembles physiological blood vessel regression. Nature 545, 98\u2013102 (2017).","journal-title":"Nature"},{"key":"73788_CR70","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo, M. et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 391, 1163\u20131173 (2018).","journal-title":"Lancet"},{"key":"73788_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh4567","volume":"384","author":"KK Mahadevan","year":"2024","unstructured":"Mahadevan, K. K. et al. Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer. Science 384, eadh4567 (2024).","journal-title":"Science"},{"key":"73788_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01908-6","volume":"22","author":"S Van Lint","year":"2023","unstructured":"Van Lint, S. et al. A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumour microenvironment towards an antitumour state. Mol. Cancer 22, 191 (2023).","journal-title":"Mol. Cancer"},{"key":"73788_CR73","doi-asserted-by":"crossref","unstructured":"Perez, C. R. & De Palma, M. Engineering dendritic cell vaccines to improve cancer immunotherapy. Nat. Commun. 10, 5408 (2019).","DOI":"10.1038\/s41467-019-13368-y"},{"key":"73788_CR74","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson, D. E., O\u2019Keefe, R. A. & Grandis, J. R. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 15, 234\u2013248 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"73788_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202502452","volume":"37","author":"J Zhu","year":"2025","unstructured":"Zhu, J. et al. Icing on the cake: integrating optical fiber with second near-infrared aggregation-induced emission luminogen for exceptional phototheranostics of bladder cancer. Adv. Mater. 37, e2502452 (2025).","journal-title":"Adv. Mater."},{"key":"73788_CR76","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s42765-022-00210-2","volume":"5","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. NIR-II-triggered composite nanofibers to simultaneously achieve intracranial hemostasis, killing superbug and residual cancer cells in brain tumour resection surgery. Adv. Fiber Mater. 5, 209\u2013222 (2023).","journal-title":"Adv. Fiber Mater."},{"key":"73788_CR77","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41422-023-00831-1","volume":"33","author":"L Wu","year":"2023","unstructured":"Wu, L. et al. An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte\u2013tumour cell crosstalk, local immunosuppression and tumour progression. Cell Res 33, 585\u2013603 (2023).","journal-title":"Cell Res"},{"key":"73788_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cell.2025.09.021","volume":"188","author":"A Ludin","year":"2025","unstructured":"Ludin, A. et al. CRATER tumour niches facilitate CD8+ T cell engagement and correspond with immunotherapy success. Cell 188, 1\u201317 (2025).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73788-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73788-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73788-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:03:10Z","timestamp":1784685790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73788-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73788"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73788-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6944"}}